Tenderwize
Retour à la recherche

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Techniker Krankenkasse·Hamburg, Germany·Deadline Feb 27, 2027 · 185 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-06 - Dolutegravir

52/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

52 / 100

Complexité

58 / 100

Facteurs de risque

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Feb 2027
  • Supply of pharmaceutical products for the active substance Dolutegravir.
  • Open House contract for rebate agreements under Section 130c(1) SGB V.
Afficher le résumé complet

This is a German Open House pharmaceutical supply arrangement for Dolutegravir (CPV 33600000) led by Techniker Krankenkasse, with HEK and hkk listed as participating buyers. It is not a classic competitive award procedure: TK states that all suitable pharmaceutical companies meeting the stated conditions may join, with no exclusivity and no individual negotiations. The contract term runs up to 24 months from 2025-03-01 and ends no later than 2027-02-28, with possible earlier automatic end on patent/market exclusivity expiry. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the TED XML notice.

Risques

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical company within the meaning of Section 4(18) AMG for the relevant medicinal products.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Open House supply arrangement for Dolutegravir. The lot covers nationwide performance in Germany and is intended for pharmaceutical companies that can supply/market the relevant medicinal product and meet the stated Open House eligibility conditions. The notice says participation is possible throughout the contract period, subject to the stated conditions. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Feb 2025 - Feb 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Feb 27, 2027

Détails de la procédure

Date de publication
20 Jan 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
42663-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3